249 related articles for article (PubMed ID: 1443956)
21. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S
Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519
[TBL] [Abstract][Full Text] [Related]
22. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
23. Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives.
Ijichi S; Osame M
Intern Med; 1995 Aug; 34(8):713-21. PubMed ID: 8563108
[TBL] [Abstract][Full Text] [Related]
24. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
[TBL] [Abstract][Full Text] [Related]
25. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
[TBL] [Abstract][Full Text] [Related]
26. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
[TBL] [Abstract][Full Text] [Related]
27. [Tropical spastic paraparesis in a non tropical region].
Pias-Peleteiro L; Pias-Peleteiro JM; Arias M
Rev Neurol; 2015 Oct; 61(8):357-62. PubMed ID: 26461129
[TBL] [Abstract][Full Text] [Related]
28. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
29. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Shuh M; Beilke M
Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
[TBL] [Abstract][Full Text] [Related]
30. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
[TBL] [Abstract][Full Text] [Related]
31. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
Kaplan JE; Osame M; Kubota H; Igata A; Nishitani H; Maeda Y; Khabbaz RF; Janssen RS
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1096-101. PubMed ID: 2213510
[TBL] [Abstract][Full Text] [Related]
32. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
[TBL] [Abstract][Full Text] [Related]
34. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
35. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T; Ando H; Araya N; Yagishita N
Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
[TBL] [Abstract][Full Text] [Related]
36. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
37. Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Matsuura E; Matsuzaki T; Watanabe O; Kubota R; Izumo S; Takashima H
PLoS One; 2014; 9(5):e86144. PubMed ID: 24802839
[TBL] [Abstract][Full Text] [Related]
38. [HTLV-1 associated myelopathies in the city of Salvador, Bahia].
Melo A; Gomes I; Mattos K
Arq Neuropsiquiatr; 1994 Sep; 52(3):320-5. PubMed ID: 7893204
[TBL] [Abstract][Full Text] [Related]
39. A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Alvarez C; Verdonck K; Tipismana M; Gotuzzo E
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392440
[TBL] [Abstract][Full Text] [Related]
40. Systemic diseases in patients with HTLV-1-associated uveitis.
Nakao K; Abematsu N; Sakamoto T
Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
